Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02214121
Brief Title: A Pharmacokinetic (PK) and Pharmacodynamic (PD) Dose-ranging Phase II Study of Ticagrelor in Paediatric Patients With Sickle Cell Disease (HESTIA 1)

First Submitted : August 8, 2014
First Submitted that Met QC Criteria : August 8, 2014
First Posted : August 12, 2014 (Estimate)

Results First Submitted : February 5, 2018
Results First Submitted that Met QC Criteria : May 9, 2018
Results First Posted : May 11, 2018

Last Update Submitted that Met QC Criteria : November 22, 2018
Last Update Posted : December 14, 2018